Si-ping Han

Title: Si-ping Han: Innovator in Molecular Therapeutics

Introduction

Si-ping Han is a prominent inventor based in Yorba Linda, CA (US), known for his significant contributions to the field of molecular therapeutics. With a total of 8 patents, Han has focused on developing innovative solutions for treating complex medical conditions, particularly in oncology.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Conditional-siRNAS and uses thereof in treating acute myeloid leukemia." This patent discloses conditional siRNAs that are activatable by the CBFβ-MYH11 oncogenic gene, specifically targeting MCL-1 or HDAC8 for the treatment of acute myeloid leukemia (AML). Another notable patent is "Signal activatable constructs and related components compositions methods and systems." This invention provides signal activatable molecular constructs designed for the delivery of therapeutic molecules, featuring a sophisticated targeting domain and sensor strand mechanism that enhances the efficacy of treatment.

Career Highlights

Si-ping Han has had a distinguished career, working with esteemed institutions such as the California Institute of Technology and City of Hope. His work has significantly advanced the understanding and treatment of various cancers, showcasing his dedication to improving patient outcomes through innovative research.

Collaborations

Throughout his career, Han has collaborated with notable professionals in the field, including William A. Goddard III and Lisa Scherer, who have contributed to his research endeavors.

Conclusion

Si-ping Han's innovative work in molecular therapeutics has made a lasting impact on the treatment of acute myeloid leukemia and other conditions. His patents reflect a commitment to advancing medical science and improving patient care through targeted therapies.